Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice

Amy S. Major, Dwayne E. Dove, Hiroyuki Ishiguro, Ru Su Yan, Abigail M. Brown, Lily Liu, Kathy J. Carter, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The concentration of apolipoprotein (apo) AI in the artery wall is thought to enhance cellular cholesterol efflux and protect against atherosclerosis. It has been shown that although macrophages do not make apoAI, they respond to it by increased cholesterol efflux. We hypothesized that macrophage production of apoAI would increase cholesterol efflux and reduce atherogenesis. In this study, we produced mice expressing human apoAI under the control of the macrophage-specific scavenger receptor-A promoter (mφ-AI). Human apoAI was detectable in the serum HDL fraction of mφ-AI transgenic mice at concentrations too low to affect serum cholesterol or HDL levels. Immunoblotting showed the presence of human apoAI in transgenic macrophage culture supernatants, mostly as lipoprotein-free protein, with a small component associated with HDL-like particles. Atherosclerosis studies using apoAI(-/-) mice transplanted with mφ-AI bone marrow showed that in the absence of macrophage-derived apoE, local expression of apoAI reduced diet-induced lesions in the proximal aorta. Additionally, mφ-AI macrophages showed a 40% increase in cholesterol efflux compared with control macrophages. These data support the hypothesis that apoAI production by macrophages in the artery wall is protective against atherosclerosis. This protection is likely mediated by increased cholesterol efflux and decreased foam cell formation in vivo.

Original languageEnglish (US)
Pages (from-to)1790-1795
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume21
Issue number11
StatePublished - 2001
Externally publishedYes

Fingerprint

Apolipoproteins
Apolipoprotein A-I
Atherosclerosis
Macrophages
Cholesterol
Arteries
Scavenger Receptors
Foam Cells
Apolipoproteins E
Serum
Immunoblotting
HDL Cholesterol
Transgenic Mice
Lipoproteins
Aorta
Bone Marrow
Diet
Proteins

Keywords

  • ApoAI
  • Foam cell
  • Macrophage
  • Transgenic mice

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice. / Major, Amy S.; Dove, Dwayne E.; Ishiguro, Hiroyuki; Yan, Ru Su; Brown, Abigail M.; Liu, Lily; Carter, Kathy J.; Linton, MacRae F.; Fazio, Sergio.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 21, No. 11, 2001, p. 1790-1795.

Research output: Contribution to journalArticle

Major, Amy S. ; Dove, Dwayne E. ; Ishiguro, Hiroyuki ; Yan, Ru Su ; Brown, Abigail M. ; Liu, Lily ; Carter, Kathy J. ; Linton, MacRae F. ; Fazio, Sergio. / Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2001 ; Vol. 21, No. 11. pp. 1790-1795.
@article{557c033e4c4640c6b2a45978acee2996,
title = "Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice",
abstract = "The concentration of apolipoprotein (apo) AI in the artery wall is thought to enhance cellular cholesterol efflux and protect against atherosclerosis. It has been shown that although macrophages do not make apoAI, they respond to it by increased cholesterol efflux. We hypothesized that macrophage production of apoAI would increase cholesterol efflux and reduce atherogenesis. In this study, we produced mice expressing human apoAI under the control of the macrophage-specific scavenger receptor-A promoter (mφ-AI). Human apoAI was detectable in the serum HDL fraction of mφ-AI transgenic mice at concentrations too low to affect serum cholesterol or HDL levels. Immunoblotting showed the presence of human apoAI in transgenic macrophage culture supernatants, mostly as lipoprotein-free protein, with a small component associated with HDL-like particles. Atherosclerosis studies using apoAI(-/-) mice transplanted with mφ-AI bone marrow showed that in the absence of macrophage-derived apoE, local expression of apoAI reduced diet-induced lesions in the proximal aorta. Additionally, mφ-AI macrophages showed a 40{\%} increase in cholesterol efflux compared with control macrophages. These data support the hypothesis that apoAI production by macrophages in the artery wall is protective against atherosclerosis. This protection is likely mediated by increased cholesterol efflux and decreased foam cell formation in vivo.",
keywords = "ApoAI, Foam cell, Macrophage, Transgenic mice",
author = "Major, {Amy S.} and Dove, {Dwayne E.} and Hiroyuki Ishiguro and Yan, {Ru Su} and Brown, {Abigail M.} and Lily Liu and Carter, {Kathy J.} and Linton, {MacRae F.} and Sergio Fazio",
year = "2001",
language = "English (US)",
volume = "21",
pages = "1790--1795",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice

AU - Major, Amy S.

AU - Dove, Dwayne E.

AU - Ishiguro, Hiroyuki

AU - Yan, Ru Su

AU - Brown, Abigail M.

AU - Liu, Lily

AU - Carter, Kathy J.

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2001

Y1 - 2001

N2 - The concentration of apolipoprotein (apo) AI in the artery wall is thought to enhance cellular cholesterol efflux and protect against atherosclerosis. It has been shown that although macrophages do not make apoAI, they respond to it by increased cholesterol efflux. We hypothesized that macrophage production of apoAI would increase cholesterol efflux and reduce atherogenesis. In this study, we produced mice expressing human apoAI under the control of the macrophage-specific scavenger receptor-A promoter (mφ-AI). Human apoAI was detectable in the serum HDL fraction of mφ-AI transgenic mice at concentrations too low to affect serum cholesterol or HDL levels. Immunoblotting showed the presence of human apoAI in transgenic macrophage culture supernatants, mostly as lipoprotein-free protein, with a small component associated with HDL-like particles. Atherosclerosis studies using apoAI(-/-) mice transplanted with mφ-AI bone marrow showed that in the absence of macrophage-derived apoE, local expression of apoAI reduced diet-induced lesions in the proximal aorta. Additionally, mφ-AI macrophages showed a 40% increase in cholesterol efflux compared with control macrophages. These data support the hypothesis that apoAI production by macrophages in the artery wall is protective against atherosclerosis. This protection is likely mediated by increased cholesterol efflux and decreased foam cell formation in vivo.

AB - The concentration of apolipoprotein (apo) AI in the artery wall is thought to enhance cellular cholesterol efflux and protect against atherosclerosis. It has been shown that although macrophages do not make apoAI, they respond to it by increased cholesterol efflux. We hypothesized that macrophage production of apoAI would increase cholesterol efflux and reduce atherogenesis. In this study, we produced mice expressing human apoAI under the control of the macrophage-specific scavenger receptor-A promoter (mφ-AI). Human apoAI was detectable in the serum HDL fraction of mφ-AI transgenic mice at concentrations too low to affect serum cholesterol or HDL levels. Immunoblotting showed the presence of human apoAI in transgenic macrophage culture supernatants, mostly as lipoprotein-free protein, with a small component associated with HDL-like particles. Atherosclerosis studies using apoAI(-/-) mice transplanted with mφ-AI bone marrow showed that in the absence of macrophage-derived apoE, local expression of apoAI reduced diet-induced lesions in the proximal aorta. Additionally, mφ-AI macrophages showed a 40% increase in cholesterol efflux compared with control macrophages. These data support the hypothesis that apoAI production by macrophages in the artery wall is protective against atherosclerosis. This protection is likely mediated by increased cholesterol efflux and decreased foam cell formation in vivo.

KW - ApoAI

KW - Foam cell

KW - Macrophage

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0035571680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035571680&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 1790

EP - 1795

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -